The degree of semaglutide-induced weight loss in this study exceeded the EMA and FDAs criteria for anti-obesity drugs and there were no safety concerns, indicating the potential of once-daily subcutaneous semaglutide as an anti-obesity drug in the future
In this comprehensive article, you will learn how tirzepatide and orforglipron work in the body, which medication is more effective, and what the side effects and safety concerns are for each medication
Nausea, vomiting, and diarrhoea are particularly common, especially during treatment initiation or dose titration
Like GLP-1, it increases satiety by slowing gastric emptying & changing our appetite preferences
Patients on PlexusDx's compounded semaglutide program can contact their care team to discuss adherence strategies, dosing adjustments, or the Precision Peptide Genetic Test to understand their individual response patterns and optimize their treatment plan